The emerging treatment of the medication represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment